Articles de revue sur le cancer du cerveau - Derniè res parutions

InTextoResearch, agence d'information scientifique


InTextoResearch vous informe sur les dernières parutions d'articles de
revue sur les cancers du cerveau (7 février 2008):

Glioblastoma multiforme: the role of DSB repair between genotype and
phenotype.
Fischer U, Meese E.
Oncogene. 2007 Dec 10;26(56):7809-15.

Adjuvant chemotherapy for adults with malignant glioma: a systematic
review.
Perry J, Laperriere N, Zuraw L, Chambers A, Spithoff K, Cairncross JG;
Neuro-oncology Disease Site Group; Cancer Care Ontario Program in
Evidence-Based Care.
Can J Neurol Sci. 2007 Nov;34(4):402-10.

Mechanisms of Disease: the PI3K-Akt-PTEN signaling node--an intercept
point for the control of angiogenesis in brain tumors.
Castellino RC, Durden DL.
Nat Clin Pract Neurol. 2007 Dec;3(12):682-93.

Molecular pathology of malignant gliomas.
Louis DN.
Annu Rev Pathol. 2006;1:97-117.

Cancer stem cells as mediators of treatment resistance in brain
tumors: status and controversies.
Sakariassen PØ, Immervoll H, Chekenya M.
Neoplasia. 2007 Nov;9(11):882-92.

Management of optic-hypothalamic gliomas in children: still a
challenging problem.
Massimi L, Tufo T, Di Rocco C.
Expert Rev Anticancer Ther. 2007 Nov;7(11):1591-610.

Cancer stem cells and brain tumors: uprooting the bad seeds.
Lee da Y, Gutmann DH.
Expert Rev Anticancer Ther. 2007 Nov;7(11):1581-90.

Inhibition of angiogenesis and invasion in malignant gliomas.
Chi A, Norden AD, Wen PY.
Expert Rev Anticancer Ther. 2007 Nov;7(11):1537-60.

Brain tumors.
Pöpperl G, Tatsch K, Kreth FW, Tonn JC.
Recent Results Cancer Res. 2008;170:33-47.

Roles of HMGA proteins in cancer.
Fusco A, Fedele M.
Nat Rev Cancer. 2007 Dec;7(12):899-910.

New molecular targets in malignant gliomas.
de Groot JF, Gilbert MR.
Curr Opin Neurol. 2007 Dec;20(6):712-8.

Incorporating molecular tools into clinical trials and treatment for
gliomas?
Lassman AB, Holland EC.
Curr Opin Neurol. 2007 Dec;20(6):708-11.

Dipeptidyl peptidase-IV enzymatic activity bearing molecules in human
brain tumors--good or evil?
Busek P, Stremenova J, Sedo A.
Front Biosci. 2008 Jan 1;13:2319-26.

Sphingolipid signaling pathways as potential therapeutic targets in
gliomas.
Van Brocklyn JR.
Mini Rev Med Chem. 2007 Oct;7(10):984-90.

Malignant astrocytic glioma: genetics, biology, and paths to
treatment.
Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn
WC, Ligon KL, Louis DN, Brennan C, Chin L, DePinho RA, Cavenee WK.
Genes Dev. 2007 Nov 1;21(21):2683-710.

Autocrine factors that sustain glioma invasion and paracrine biology
in the brain microenvironment.
Hoelzinger DB, Demuth T, Berens ME.
J Natl Cancer Inst. 2007 Nov 7;99(21):1583-93.

Anaplastic oligodendroglioma and oligoastrocytoma.
van den Bent MJ.
Neurol Clin. 2007 Nov;25(4):1089-109, ix-x



(contact pour InTextoResearch: Marc Lacroix, Baelen, Wallonie,
Belgique - scimedweb@mail.com)